Class action lawsuit filed against Dr Reddy's in US
Drug firm Dr Reddy's Laboratories on Monday said a class action lawsuit has been filed against it in the US by an investor alleging misleading statements in violation of the US federal securities laws.
Aug 28, 2017, 15:28 PM IST
USFDA completes inspection of Cadila's Changodar plant
Drug firm Cadila Healthcare today said the USFDA has completed inspection of its manufacturing plant at Changodar with "no observation".
Apr 07, 2017, 17:35 PM IST
Divis Labs Q1 net spurts 45% to Rs 243 crore
Drug firm Divis Laboratories today reported a 45 per cent rise in its net profit at Rs 243.18 crore for the June quarter, from Rs 167.93 crore a year ago.
Aug 08, 2015, 16:23 PM IST
US court rejects Glenmark's patent plea for Finacea
Drug firm Glenmark's generic skin care drug that was under patent litigation infinges patent of Bayer, a US court has ruled.
Jul 28, 2015, 23:25 PM IST
Lupin Q1 net dips by 16% at Rs 525.02 cr
The company had posted a net profit after taxes and minority interest of Rs 624.74 crore for the corresponding period of the previous fiscal, Lupin said in a filing to BSE.
Jul 23, 2015, 16:08 PM IST
Sanofi India Q2 net up 12% at Rs 64.2 crore
Drug firm Sanofi India Tuesday reported a 11.65 percent rise in its standalone net profit at Rs 64.2 crore during second quarter ended June 30, 2015.
Jul 21, 2015, 22:13 PM IST
FIL Capital to invest in Cipla's consumer healthcare biz
Drug major Cipla on Tuesday said its board has approved a potential investment by FIL Capital Investments (Mauritius) II Ltd in its consumer healthcare business.
Jul 21, 2015, 11:19 AM IST
Torrent Pharma completes Zyg Pharma acquisition
Drug firm Torrent Pharmaceuticals on Saturday said that it has completed acquisition of Encore Group firm Zyg Pharma Pvt Ltd.
Jul 18, 2015, 14:00 PM IST
Wockhardt recalls over 1.62 lakh cartons of drugs in US
As per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
Jul 16, 2015, 19:05 PM IST
Pfizer to close its Navi Mumbai plant
Drug firm Pfizer is planning to close its Navi Mumbai plant from September 16, 2015.
Jul 15, 2015, 14:44 PM IST
Cadila gets USFDA nod for Pyridostigmine Bromide tablets
With this approval, the group has received 100 approvals and has so far filed 260 ANDAs (abbreviated new drug applications).
Jun 24, 2015, 12:31 PM IST
Strides Arcolab seeks shareholder nod for Rs 2k cr outlay
The approval of shareholders is sought through a postal ballot. The e-voting will commence on June 10 and end on July 9, the company said in a filing to BSE.
Jun 10, 2015, 17:55 PM IST
Lupin submits fresh studies for two products suspended by EMA
The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.
May 26, 2015, 14:10 PM IST
Divis Labs gains from sales surge, Q4 net up 18%
The company had posted a net profit of Rs 196.43 crore in the corresponding period of the previous fiscal, Divis Laboratories said in a filing to BSE.
May 23, 2015, 14:58 PM IST
Lupin acquires Brazilian drug firm Medquimica
Drug major Lupin Wednesday announced acquisition of Brazil's Medquimica Industria Farmaceutica SA, marking its foray into the Latin American nation.
May 13, 2015, 21:31 PM IST
Claris gets USFDA supplemental nod for Fluconazole injection
"The company has received the supplemental Abbreviated New Drug Application (ANDA) for Fluconazole injection in the US," Claris Lifesciences said in a filing to the BSE.
Apr 21, 2015, 13:53 PM IST
Lupin launches anti-bacterial Zaxine tablets in Canada
Zaxine 550 mg (rifaximin) is a long-term antibiotic treatment drug for adults living with hepatic encephalopathy (HE), a complication of liver disease (cirrhosis).
Apr 20, 2015, 14:17 PM IST
Dr Reddy's to buy UCB's select brands for Rs 800 crore
"The acquired business is being sold on a slump sale basis. The revenues of the acquired business is approximately Rs 150 crore for the calendar year 2014," it added.
Apr 01, 2015, 14:43 PM IST
Aurobindo gets tentative nod from USFDA for Lacosamide tablets
Drug firm Aurobindo Pharma has received tentative approval from the US health regulator USFDA for its generic Lacosamide tablets used in treatment of partial seizures in epilepsy patients.
Mar 19, 2015, 17:32 PM IST
Lupin launches asthma drug delivery device in US
The agreement grants Lupin exclusive rights to promote, distribute and market InspiraChamber VHC in the US, it added.
Feb 18, 2015, 17:54 PM IST
